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Edited by Francesc PosasAbstract The canonical mitogen-activated protein kinase
(MAPK) signal cascade was previously suggested to be atypical
in the malaria parasite. This raises queries on the existence of
alternative mediators of plasmodial MAPK pathways. This
study describes, Pfnek3, a malarial protein kinase belonging to
the NIMA (Never in Mitosis, Aspergillus) family. Endogenous
Pfnek3 is expressed during late asexual to gametocyte stages
and lacks some classical protein kinase sequence motifs. More-
over, Pfnek3 is phylogenetically distant from mammalian
NIMA-kinases. Recombinant Pfnek3 was able to phosphorylate
and stimulate a malarial MAPK (Pfmap2). Contrastingly, this
was not observed with two other kinases, Pfmap1 and human
MAPK1, suggesting that the Pfnek3–Pfmap2 interaction may
be speciﬁc for Pfmap2 regulation. In summary, our data reveal
a malarial NIMA-kinase with the potential to regulate a MAPK.
Possessing biochemical properties divergent from classical mam-
malian NIMA-kinases, Pfnek3 could potentially be an attractive
target for parasite-selective anti-malarials.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Plasmodium falciparum is responsible for the most lethal
form of human malaria. Currently, reports of widespread re-
emergence of drug resistance exacerbate the problem [1]. To
date, the development of eﬀective vaccines has yet to produce
signiﬁcant success. Therefore, a more detailed understanding
of parasite development and growth may be vital in fortifying
our molecular arsenal against the disease. The malaria life cy-
cle is appreciably complex [2]. Brieﬂy, the sporozoites target
the liver upon inoculation by the mosquito vector and develop
into asexual forms that infect red blood cells speciﬁcally. Dur-
ing the asexual intraerythrocytic stage, some parasites developAbbreviations: MAPK, mitogen-activated protein kinase; MAPKK,
MAPK kinase; NIMA, never in mitosis, Aspergillus; NEK, NIMA-
related kinase; Pfnek, Plasmodium falciparum NIMA-related kinase;
Pfmap, Plasmodium falciparum MAP kinase; hMAPK1, human MA-
PK 1; GST, glutathione-S-transferase; MBP, myelin basic protein; FL,
full-length; TR, truncated; PBS, phosphate buﬀered saline; BSA, bo-
vine serum albumin; ELISA, enzyme-linked immunosorbent assay;
WB, Western blot; Ctrl, control
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quito. In the mosquito midgut, the gametocytes fuse and form
zygotes that escape the midgut and transform into sporozoites
that migrate to the vector’s salivary glands, ready to infect a
new host. Surprisingly, the signaling mechanisms throughout
the entire developmental process are poorly understood. It
has been established in other eukaryotic cells that molecular
signaling is a key to a cell’s fate. Therefore, it is reasonable
to suggest that signal transduction control is essential to para-
site growth. A methodical approach to unveil these pathways
may therefore lead to the identiﬁcation of important signaling
mediators.
We are interested in understanding the role of protein kinase
pathways in the malaria parasite. Among eukaryotes, protein
kinases belonging to the mitogen-activated protein kinase
superfamily (MAPK, also called ERK, extracellularly regulated
kinase) are currently among the best understood. MAPKs are
believed to be highly conserved among eukaryotes and are cen-
tral to the transduction of extracellular mitogenic stimuli down
a cascade of ATP-dependent protein kinases. Two copies of P.
falciparumMAPKs (Pfmap1 and Pfmap2) have been identiﬁed
so far [3,4]. Both MAPKs share a peptide sequence identity of
41% in their catalytic domain. Phosphorylation of a threo-
nine–tyrosine (TXY) sequence motif by an upstream kinase is
usually needed for the activation of classical MAPKs. The
TXY motif is completely conserved in Pfmap1 as TDY (Plas-
moDB identiﬁer: PF14_0294), and is evolutionarily altered to
TSH in Pfmap2 (PlasmoDB identiﬁer: PF11_0147). Pbmap2,
the Plasmodium berghei counterpart of Pfmap2 was recently
demonstrated to regulate gametogenesis via gene-disruption
studies as well as in sex-speciﬁc proteomic analyses [5,6].
To further understand molecular mechanisms regulating the
development of the parasite, protein kinase genes highly-ex-
pressed in gametocytes were strategically identiﬁed from tran-
scriptome data deposited in PlasmoDB.org, and cloned for
biochemical characterization. The result of data-mining re-
vealed four Plasmodium genes clustered as sequences with
homology to the NIMA (Never in Mitosis, Aspergillus) protein
kinase family [7]. Of these four genes, three were revealed by
microarray data to be expressed predominantly in gametocytes
[8,9]. The founding member of the NEK family, NIMA, was
described in Aspergillus nidulans and shown to be required
for G2/M transition [10]. Thus far, other NIMA homologues
have been identiﬁed in many eukaryotes, and there is growing
evidence that NIMA-family kinases (NEKs) play the role of
cell cycle regulators [11].
Numerous attempts have been made to identify candidate
kinases upstream of Pfmap1 and Pfmap2. For example, it
has previously been suggested that Pfnek1, a NIMA-familyblished by Elsevier B.V. All rights reserved.
6084 Y.M. Lye et al. / FEBS Letters 580 (2006) 6083–6092kinase is an upstream regulator (i.e. MAPKK, also called
MEK, MAPK/ERK Kinase) of Pfmap2 [12]. Unfortunately,
bona ﬁde in vivo activity of Pfnek1 was not established and re-
combinant Pfnek1 did not stimulate Pfmap1 [12]. A second
protein kinase, PfPK7, with a MEK-like motif was reported
[13]. Interestingly, its sequence similarity to MEKs is limited
to the C-terminal domain while its N-terminal region bears
similarity to PKAs (protein kinase A). In view of the above,
and the fact that the malaria kinome reveals the lack of other
MEK-coding DNA sequences [7], Dorin et al. suggested that a
regular three-step MAP kinase cascade is possibly non-existent
in the malaria parasite [13]. Thus, the existence of unusual sig-
naling mediators that can regulate plasmodial MAPKs re-
mains an intriguing question of Plasmodium biology.
The advent of the PlasmoDB repository (www.PlasmoDB.
org) has eased our search for potential signaling mediators.
Capitalizing on the transcriptome data oﬀered in PlasmoDB
[8,9], it was possible to identify a range of annotated gene
products with expression proﬁles well-correlated with Pfmap1
and/or Pfmap2. We were intrigued by a sequence identiﬁed as
PFL0080c (herein after referred to as Pfnek3 following [7]), be-
cause it has an asexual intraerythrocytic expression proﬁle akin
to that of Pfmap1 whilst also being highly up-regulated during
the gametocyte stage, where Pfmap2 is speciﬁcally expressed
[4]. The results in this study demonstrate (i) the biochemical
characterization of Pfnek3, (ii) the enhancement of Pfmap2 ki-
nase activity by Pfnek3 and (iii) expression of Pfnek3 in the
blood stages of the malaria parasite.2. Materials and methods
2.1. Parasite cultures
The source of P. falciparum Tan strain was National University
Hospital, Singapore. Parasite line 3D7 (MRA-102, MR4, ATCC
Manassas Virginia) was a gift from MR4, the malaria resource repos-
itory (http://www.malaria.mr4.org/). The parasites were grown in
human erythrocytes as described previously [14].
2.2. Molecular cloning and site-directed mutagenesis of Pfnek3 cDNA
Genomic DNA and total RNA were extracted from asynchronous
cultures of intraerythrocytic P. falciparum (Tan and 3D7 strains) using
the QIAamp DNA Blood Mini Kit and RNeasy Mini Kit, respec-
tively (Qiagen, Germany). The Sensiscript RT kit (Qiagen, Germany)
was used to reverse-transcribe Pfnek3 from a poly-A+ mRNA-enriched
template using a reverse primer, OL768, 5 0-gaattcTTATTGAACCGT-
TATACAT-3 0 (EcoRI site lowercase) for ﬁrst strand synthesis prior to
thermocycling. To verify the intron structure of the Pfnek3 gene, PCR
was performed on intraerythrocytic parasite genomic DNA using a
pair of primers, (OL771) 5 0-ggatccGTTTGCATTTACTTGTTTT-30
(BamHI site lowercase) and OL768 (sequence above).
As evident in other studies, the presence of N-terminal hydrophobic
regions in a recombinant protein may interfere with subsequent expres-
sion in Escherichia coli [15]. Therefore, the truncated form of
the Pfnek3 gene encoding a peptide lacking the ﬁrst 59 amino acids
was ampliﬁed using another forward primer, (OL767) 5 0-
ggatccTGTGAGAAGAAATACCAGG-3 0 (BamHI site lowercase).
All genes were ampliﬁed with Pfu DNA polymerase (Promega,
USA) using thermocycling parameters previously described [16].
PCR and RT-PCR products were gel-puriﬁed and ligated onto the
pCR-BluntII-TOPO (Invitrogen, USA). Positive constructs were ver-
iﬁed by DNA sequencing. The cloned full-length and truncated Pfnek3
sequences were thereafter named FL-Pfnek3 and TR-Pfnek3, respec-
tively. Mutant, ‘kinase-dead’ enzymes were constructed using the
overlap extension protocol [17]. A K102M mutation was intro-
duced at the kinase sub-domain II into the plasmid carrying TR-
Pfnek3 to generate a catalytically-inactive recombinant kinase
(called DPfnek3). The primer pair used was (OL979) 5 0-GAGAT-ATATATATCTatgGTATATGATATATATGG-3 0 and (OL980) 5 0-
CCATATATATCATATACCATAGATATATATATCTC-3 0. The
plasmid carrying GST-Pfmap2 (a gift from C. Doerig, Wellcome Cen-
tre for Molecular Parasitology) was similarly mutated at K135 using
(OL1138) 5 0-CAAATAAAAATGTGGCTATAatgAAGGTTAA-
TAG-3 0 and (OL1139) 5 0-CTATTAACCTTCATTATAGCCA-
CATTTTTATTTG-3 0.
2.3. Recombinant kinase production
FL-Pfnek3, TR-Pfnek3 and TR-DPfnek3 fragments were sub-cloned
into GST-encoding pGEX-6P-1 vectors (Amersham, Sweden) using
standard molecular techniques. Diﬀerentially tagging Pfnek3 to the
6xHis moiety allows for kinase assays involving a few kinases to be
examined in detail. Therefore, PCR fragments for TR-Pfnek3 and
TR-DPfnek3 were cloned into the 6xHis-encoding pDEST17 vector
using Gateway technology (Invitrogen, USA). E. coli BL21 (DE3)
or the CodonPlus strain (Stratagene, USA) was electro-transformed
with the recombinant plasmids. Using the Rare Codon Analyzer from
the University of California (http://www.doe-mbi.ucla.edu/~sumchan/
caltor.html), 43 rare codons were found in this 347-residue protein.
Of the 43 rare codons found, 29 speciﬁcally utilized the rare AUA
codon to code for isoleucine. Therefore, attempts were made to express
the same genes in CodonPlus cells engineered to alleviate codon bias.
Successful transformants were induced to express fusion proteins by
overnight incubation with 0.5 mM IPTG (isopropyl-beta-D-thiogalac-
topyranoside) at 22–25 C. Cells were sonicated (MSE Soniprep,
Sanyo) and lysates cleared by centrifugation. Supernatants were
aﬃnity-puriﬁed with glutathione-sepharose or Ni-NTA according to
manufacturer’s instructions (Amersham, Sweden; Qiagen, Germany).
GST-Pfmap1 and GST-Pfmap2 (gifts from C. Doerig) were expressed
similarly in CodonPlus cells. In some experiments, recombinant pro-
teins were cleaved of their fusion partner (GST) by incubating for at
least three hours at 4 C with the Precission protease (Amersham,
Sweden). Eluted proteins were analyzed with SDS–PAGE. Protein
expression levels were determined using the Protein Assay Reagent
(Bio-Rad, USA). A GST-tagged human MAP kinase (hMAPK1)
was purchased from Upstate (USA) for use as a positive control.
2.4. Protein adsorption
To assay for kinase substrate preference, a panel of four polypep-
tides (pre-diluted to 0.5 mg/ml) was adsorbed to protein-binding 96-
well plates (Costar, USA): (i) histone H1, (ii) casein kinase I substrate
(peptide sequence RRKDLHDDEEDEAMSITA), (iii) casein kinase II
substrate (peptide sequence RRADDSDDDDD; all from Calbiochem,
USA) and (iv) dephosphorylated myelin basic protein (MBP; Upstate,
USA). Similarly, GST-fusion kinases were also adsorbed for use as
substrates for other kinases. Adsorption was achieved by overnight
incubation of the proteins in microplate wells at 4 C in a carbonate
buﬀer (0.15 M sodium carbonate and 0.35 M sodium bicarbonate,
pH 9.6). Before use, remaining adsorptive surfaces were blocked with
PBS/1% BSA for one hour at room temperature. To control well-to-
well consistency of the coated microplates, MBP-coated wells were as-
sayed with hMAPK1 to ensure uniform adsorption. To ascertain equal
binding of diﬀerent GST-tagged kinases to the microplate wells, anti-
GST primary antibodies (1:1000 dilution; Sigma, USA) were used to
detect adsorbed enzymes, and processed with standard peroxidase-
based chemiluminescence to demonstrate uniform adsorption.
2.5. Validation of the ELISA-based kinase assay
Autoradiography is commonly used for protein kinase assays. How-
ever, to facilitate future high-throughput inhibitor screens, a chemilu-
minescent microplate assay was chosen in this study. The performance
of the MBP-coated microplates prepared in this study was bench
marked against commercially-available ones by adapting the manufac-
turer’s quality control protocol using human MAPK1 (Upstate, USA
cat. no. 30-011). To optimize plate reader sensitivity, between 1 and
100 ng of human MAPK1 (per reaction of 30 ll) was tested with a
range of ATP concentrations (100–500 lM) to determine whether
maximal levels of MBP phosphorylation could be consistently
achieved.2.6. Protein kinase assay
Each kinase reaction mix of 60 ll comprised 10 lg of GST-fusion ki-
nase or the inactive mutant as control, Tris–HCl (50 mM, pH 7.2),
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tively). The kinase mixes were incubated for 30 min at 30 C. Any
phosphorylation activity in the kinase mixes were stopped by adding
Laemmli’s buﬀer [18] and denatured at 95 C for 5 min. The denatured
kinase mixes were resolved on 10% SDS–polyacrylamide gels and sub-
jected to the Pro-Q phosphoprotein gel stain (Invitrogen, USA). The
major advantage of the enzyme-linked immunosorbent assay (ELISA)
architecture lies in the use of the microplate which is amenable to high-
throughput inhibitor screenings. In view of this, 30 ll fractions of the
aforesaid kinase mixes were transferred into substrate-coated ELISAFig. 1. Sequence alignment of Pfnek3 with other NEKs and comparison of
stretch of 59 primarily hydrophobic residues was predicted to be a signal p
respectively, the PlasmoAP, PATS (score: 0.662 of 1) and TMHMM2 algorit
subdomain model of eukaryotic protein kinases (indicated with Roman-num
completely devoid of all three Gs in the glycine triad (GXGXXG) characteri
80–85), a lysine residue, potentially important for ATP binding is conserve
Pfnek3. (B) Schematic diagram of the Pfnek3 domain architecture compared
BLASTp searches. Both kinases share a sequence identity of about 10% at the
the ScanProsite tool at www.expasy.org (Pfnek3: residues 52–334; human NE
exempliﬁed by Pfnek3 having limited accessory domains. Abbreviations: RC
region.microplates immediately after the assembly of the mixtures, to assay
their kinase activities. The microplates were simultaneously incubated
at 30 C for 30 min and thereafter quenched by repeated washing with
PBS. The quenched microplate kinase assays were blocked for 30 min
with PBS/1% BSA and then incubated with mixed monoclonal anti-
phosphoserine/threonine antibodies (1:500 dilution; Upstate, USA).
The microplate was then subjected to a peroxidase-conjugated second-
ary antibody (1:4000, Upstate, USA) and the SuperSignal West Femto
peroxidase substrate (Pierce, USA). Any resulting chemiluminescence
due to the presence of phosphorylated serine and/or threonine residuesdomain architecture with the closest homologue. (A) An N-terminal
eptide and organelle-targeting signal or transmembrane region using,
hms [25–27]. Pfnek3 does not exhibit complete agreement with the 11-
bered boxes). For example, Pfnek3 belongs to a minority of kinases
stic of subdomain I. Although Pfnek3 lacks the glycine triad (residues
d at K102. Mutation at this residue obliterates the kinase activity of
to human NEK9, its closest homologue identiﬁed by non-redundant
ir respective kinase domains. The kinase domains were demarcated with
K9: residues 52–308). A marked divergence of protein architectures is
C, Regulator of chromosome condensation domain; NTR, N-terminal
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In some experiments, two diﬀerent GST-fusion kinases were co-incu-
bated in the kinase mixes to detect any in vitro diﬀerence in phospho-
transfer activity. As controls, either one of the two GST-fusion kinases
was replaced with its respective kinase-dead mutant.
2.7. Western blot
As an alternative to the Pro-Q phosphoprotein gel stain, kinase
reactions were performed as described above with the exception that
2.5 lg of MBP was included in the reaction mix as kinase substrate.
The mixture was then subjected to SDS–PAGE and transferred to
PVDF (polyvinyldiﬂuoride; Millipore, USA) membranes and probed
with a monoclonal anti-phosphoserine/threonine antibody mix (Up-
state, USA) and visualized by chemiluminescence with a peroxidase-
conjugated antibody (Pierce, USA) and the SuperSignal West Femto
reagent (Pierce, USA).
2.8. Antibody production
An aﬃnity-puriﬁed anti-Pfnek3 antibody was prepared by Gene-
Script Corp. (New Jersey, USA). Two New Zealand White rabbits
were immunized with a synthetic peptide derived from the Pfnek3
amino acid sequence (NQGDLHSDILRKKLC, residues 154–167).
The terminal cysteine residue was incorporated to allow coupling to
keyhole limpet hemocyanin. The antibody was tested using ELISA
and Western blot (WB) prior to ﬂuorescence microscopy. To verify
the speciﬁcity of anti-Pfnek3, protein-adsorbing microplates were used,
as described in Protein adsorption, to bind GST-Pfmap2, GST-Pfnek3
or their kinase-inactive mutants. Microplates were probed using a
1:1000 dilution of anti-Pfnek3 and processed for chemiluminescence
as described earlier under Protein kinase assay. To further verify the
speciﬁcity of anti-Pfnek3, puriﬁed recombinant GST-Pfmap2 and
GST-Pfnek3 were subjected to Western blot, as described above, and
probed with a 1:1000 dilution of anti-Pfnek3, followed by a peroxi-
dase-conjugated anti-rabbit secondary antibody. Visualization was
achieved using a peroxidase substrate, TMB (3,3 0,5,5 0-tetramethyl-
benzidine; Sigma, USA).
2.9. Immunoﬂuorescence microscopy
Gradient-centrifugation enriched parasites (both sexual and asexual
stages) were smeared, air-dried and ﬁxed on poly-L-lysine slides using
4% paraformaldehyde/PBS. Fixed cells were permeabilized with 0.1%
Triton X-100/PBS, and immunolabelled with the aﬃnity-puriﬁed
Pfnek3 antibody. This was followed by a ﬂuorescein isothiocyanateFig. 2. Phylogenetic analysis. The full-length Pfnek3 amino acid sequence wa
databases via BLASTp program at the Expasy website (www.expasy.org). I
sequences were extracted and submitted to the ClustalW sequence alignme
TreeView program (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html).
homologue (Pbnek2) from mammalian NEKs. Abbreviations: PK, protein kin
sequence identiﬁer.(FITC)-conjugated anti-rabbit secondary antibody (1:33 dilution;
Acris antibodies, Germany). Slides were washed in PBS containing
0.1% Tween 20. DNA was stained with Hoechst 33342 (Invitrogen,
USA) at a ﬁnal concentration of 5 lg/ml. Cover slips were mounted
with 90% glycerol in 50 mM Tris (pH 8.0) containing 2.5% (w/v) 1,4-
diazabicyclo[2.2.2]octane (Sigma, USA) and viewed with an Olympus
BX60 ﬂuorescence microscope with the same microscope and camera
settings for images stained with the same ﬂuorophore.3. Results and discussion
3.1. Bio-computational identiﬁcation of Pfnek3
The predicted ORF of Pfnek3 encodes a protein with limited
homology of about 10% sequence identity at its kinase domain
to its closest NEK family member, human NEK9, identiﬁed by
BLASTp searches (Fig. 1). This was carried out independently
and agrees with the biocomputational data of [19]. The infor-
mation contrasted against a phylogenetic tree plotted using
ClustalW which placed Pfnek3 in a diﬀerent clade from mam-
malian NEKs (Fig. 2). In comparison to the ﬁrst malarial
NEK reported (Pfnek1), Pfnek3 is hardly similar in terms of
residue composition (17% identity) and peptide length (1057
and 347 amino acids, respectively). Close scrutiny of the align-
ment data revealed a few peculiarities which may explain the
uniqueness of Pfnek3 (Fig. 1). Firstly, the major region of sim-
ilarity with human NEK9 is embedded only in the kinase do-
main. Secondly, a putative N-terminal signal sequence and
localization signal or transmembrane region in Pfnek3 pre-
dicted by the PlasmoAP, PATS and TMHMM2 algorithms,
respectively, may give an indication of an unknown cellular
localization. Thirdly, Pfnek3 appears to be devoid of any ki-
nase activation motif commonly located at subdomain VIII
(Fig. 1). Collaterally, Pfnek1 lacks the classical NIMA activa-
tion motif, FXXT, at subdomain VIII which was replaced by a
SMAHS motif reminiscent of a MEK activation site [12] (in-
cluded in Fig. 1 for comparison). Interestingly, Pfnek3 lackss used to query the Swiss-Prot and TrEMBL non-redundant generalist
ncompletely annotated sequences were ﬁltered out and the remaining
nt package, which generated alignment dendrograms viewed with the
The dendrogram detaches Pfnek3, as well as the rodent malarial
ase; sp, Swiss-Prot database sequence identiﬁer; tr, TrEMBL database
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Other than diﬀerences of functional motifs, there are other
molecular diﬀerences between Pfnek3 and other NEKs. For
example, the 11 sub-domains of the protein kinase catalytic
domain encoded by the ORF of Pfnek3 were not completely
in agreement with known NEKs [20]. Sub-domain I does not
contain the glycine triad (GXGXXG) principally involved in
ATP binding. Instead, the corresponding motif is altered to
FMTSDS in Pfnek3, with none of the Gs in the triad con-
served (Fig. 1). Reportedly, nearly a third of human protein ki-
nases lacks the third G of the triad, and 11% lack the ﬁrst one
[21]. So far, a small collection of kinases, for example, Schizo-
saccharomyces pombeMIK1, are reportedly devoid of all three
Gs but retain protein kinase activity [22], and this may now
include Pfnek3. Also, the highly conserved lysine residue in
sub-domain II that is critical to contacting, anchoring and ori-Fig. 3. Molecular cloning and recombinant expression of Pfnek3. (A) M
product. TR: TR-Pfnek3 ampliﬁcation product. (B) Expression of GST-tag
Pfnek3 via analytical gel ﬁltration indicates enriched fractions of monomersenting the a- and b-phosphates of ATP could not be detected
initially using PROSITE algorithms. However, based on multi-
ple sequence alignments with other protein kinases, it was
putatively identiﬁed as K102. Intriguingly, the residues in the
vicinity of K102 in Pfnek3 (Fig. 1) have deviated from consen-
sus sequences reported in other NIMA-related kinases [20].
Furthermore, the HRDXXXXN base-acceptor motif of
eukaryotic protein kinases in sub-domain VIb is represented
by a diﬀerent motif, HGDLKSTN. Since the frequency of a
glycine appearing in this sub-domain among eukaryotic pro-
tein kinases is believed to be low [20], this particular glycine
(G199) serves as an interesting target, therefore, warranting
further studies on its role. Finally, the aspartate residue con-
served in the DFG motif of sub-domain VII (D217), is thought
to elicit the binding of Mg2+or Mn2+ ion associated with the b-
and c-phosphates of ATP. And since the Pfnek3 sequence= k/HindIII molecular weight markers. FL: FL-Pfnek3 ampliﬁcation
ged kinases. (C) Analysis of puriﬁed GST-FL-Pfnek3 and GST-TR-
of about 60 kD.
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IIHGDLKSTNIF (PROSITE identiﬁer: PS00108), this aspar-
tate residue is believed to be similarly involved in phospho-
transfer catalysis.3.2. Molecular cloning of FL- and TR-Pfnek3
The Pfnek3 ORF was ampliﬁed using either cDNA or geno-
mic DNA from P. falciparum Tan or 3D7 strains as template,
and the ampliﬁed product size appeared identical (1 kb) sug-
gesting that the Pfnek3 gene is non-intronic, as was later con-
ﬁrmed by DNA sequencing. The Pfnek3 DNA sequence from
the 3D7 strain varied from the Tan stain at a single base
(Aﬁ C at nucleotide 975). The Tan strain Pfnek3 DNA was
retained for further work. The cloning of a truncated Pfnek3
(TR-Pfnek3; Fig. 3A) was necessitated by the fact that the
59-residue hydrophobic N-terminal domain of the full-length
version (FL-Pfnek3), which was predicted to be a signal pep-
tide or an organelle-targeting signal (indicated in Fig. 1) and
therefore interfere with the solubility of the expressed recombi-
nant protein. The conceptually-translated FL-Pfnek3 is 347
amino acids long and SDS–PAGE indicated that the GST-fu-
sion protein was approximately 60 kD (Fig. 3B). Analytical gel
ﬁltration of FL- and TR-Pfnek3 revealed that recombinant
Pfnek3 existed primarily as monomers of molecular weights
similar to that on SDS–PAGE gels (Fig. 3C).Fig. 4. Factors aﬀecting Pfnek3 kinase activity. (A) Substrate prefer-
ence screening of recombinant truncated (TR) Pfnek3 reveals a
preference for myelin basic protein (MBP) in the co-presence of
magnesium and manganese. (B) Kinase activities of GST-TR-Pfnek3
and its ‘kinase-dead’ mutant in the presence of Mg++ and/or Mn++
reveals a preference for Mn++ as cofactor when MBP was used as
substrate. Substrates used were MBP (dephosphorylated myelin basic
protein), CKSI (casein kinase I substrate), CKSII (casein kinase II
substrate) and histone H1. (C) The kinase activity of recombinant FL-
Pfnek3 is suppressed by the presence of an N-terminal putative signal
sequence and organelle-targeting signal and/or transmembrane region.
Kinase activities are expressed as ‘‘fold over GST ctrl’’ for the purpose
of normalizing batch-to-batch assays. A GST control consisted of
adsorbed substrates assayed with bacterially-expressed GST to estab-
lish background phosphorylation.3.3. Kinase activity of recombinant Pfnek3
The ELISA-based kinase assay has been benchmarked
against commercial systems as described in Section 2. To inves-
tigate whether the sequence divergence of Pfnek3 from mam-
malian NEK family members is reﬂected by its functional
properties, kinase assays were performed with a panel of sub-
strates and cofactors (Fig. 4). Catalytic activity of recombinant
Pfnek3 was assayed using four compounds as kinase sub-
strates: (i) MBP, (ii) histone H1, (iii) casein kinase I peptide
substrate (CKS I) and (iv), casein kinase II peptide substrate
(CKS II). Biochemical data indicated that Pfnek3 satisfactorily
phosphorylates an artiﬁcial substrate MBP but not histone H1
nor casein kinase peptide substrates (Fig. 4A). This in vitro
substrate preference is dissimilar to that of mammalian NEKs
since recombinant mammalian NEKs uses a- or b-casein but
less commonly MBP as a substrate. Hence, the in vitro sub-
strate preference of Pfnek3 is consistent with the distant rela-
tionship of this enzyme to mammalian NEKs. Contrasting to
most mammalian NEKs, Pfnek3 was a more eﬃcient kinase
when supplied with manganese as co-factor instead of magne-
sium (Fig. 4B). When a buﬀer containing both co-factors was
used, there was no increase in MBP phosphorylation, indicat-
ing that the presence of manganese was suﬃcient.
TR-Pfnek3, but not the full-length enzyme, demonstrated ki-
nase activities at levels of three- to eight-folds versus controls
using an equal amount of bacterially-expressed GST in place
of GST-TR-Pfnek3 (Fig. 4B). To verify that the phosphotrans-
fer onto MBP was indeed mediated by Pfnek3 and not by co-
puriﬁed bacterial kinases, a mutant TR-Pfnek3 carrying a
K102M substitution at its ATP-binding motif was generated
(DPfnek3) and shown to lack kinase activity (Fig. 4B).
To elucidate the eﬀect of the putative signal sequence on
downstream kinase assays, activity of the full-length protein
was also determined. GST-FL-Pfnek3 did not exhibit detect-
able kinase activities (Fig. 4C). If the N-terminal domain iserroneously predicted as a signal sequence, this data may
implicate the N-terminal domain in playing a self-regulatory
function, akin to PfPKB, where its N-terminal domain is dem-
onstrated to modulate catalytic activity [23]. To elucidate its
intricate mechanisms would probably require independent
and separate structural studies akin to studies of a kinase
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ence of an autoinhibitory peptide sequence [24]. To show that
the fusion partner (GST) did not aﬀect kinase activity, wild-
type GST-Pfnek3 was cleaved of its fusion partner and sub-
jected to the same kinase assay, with comparable results as
the fusion proteins (not shown).Fig. 5. Pfnek3 phosphorylates Pfmap2 and stimulates its kinase activity. (A
(Lane 1). The presence of either catalytically-active or inactive GST-Pfmap2
and 7). GST-TR-Pfnek3 was capable of phosphorylating GST-Pfmap2 (Lane
total protein stain (Sigma, USA) indicates uniform loading of the same pr
(Invitrogen, USA). The 45 kD band (indicated with an asterisk) corres
phosphoprotein (Invitrogen, USA) and EZ-bluestains. The 66 and 106 kD b
protein stain. NS = Non-speciﬁc protein bands ubiquitous in GST-puriﬁcatio
Pfnek3 was conﬁrmed using ELISA. GST-Pfmap2, GST-TR-Pfnek3 or their i
and used as substrate for another kinase. The values are expressed as folds ov
used in (A) were transferred to MBP-coated microplates immediately after the
Section 2. The co-incubation of GST-TR-Pfnek3 and GST-Pfmap2 produced
two kinases with a kinase-inactive mutant abolished the increased kinase activ
MBP using Western blots (Lane 4). Replacing GST-Pfmap2 with GST-hM
Pfnek3 interaction is speciﬁc (Lane 5). (F) To assess the kinase activity of G
reaction mix was applied through a Ni-NTA column to ensure removal of H
lanes, as veriﬁed by SDS–PAGE (not shown). MBP was added to the eluate a
SDS–PAGE and subjected to both phosphoprotein and total protein stain
standards (Invitrogen, USA).3.4. Pfnek3 directionally phosphorylates Pfmap2
The transcription proﬁle of Pfnek3 revealed high gametocyte
expression levels akin to Pfmap2, a gametocyte-speciﬁc
MAPK [9]. To investigate the possibility of any Pfnek3–
Pfmap2 interaction, the phosphorylation statuses of both
enzymes under identical conditions were examined. The) GST-TR-Pfnek3 alone existed as a basally phosphorylated protein
caused an increase in GST-TR-Pfnek3 autophosphorylation (Lanes 5
7). (B) The same gel in (A) stained with the EZ-blue high-sensitivity
otein in each well. M = Peppermintstick molecular weight markers
ponds to a known phosphoprotein visible with both the Pro-Q
ands (non-phosphoproteins) are only visible when stained with a total
n preparations. (C) The phosphorylation of GST-Pfmap2 by GST-TR-
nactive mutants were adsorbed to microplates as described in Section 2
er bacteria-expressed GST controls. (D) Fractions of the kinase mixes
addition of ATP and processed for chemiluminescence as described in
a markedly increased kinase activity. The replacement of any one of the
ity. (E) The observation in (D) was conﬁrmed by probing for phospho-
APK1 did not produce the same result, suggesting that the Pfmap2–
ST-Pfmap2 alone after co-incubation with His-TR-Pfnek3, the kinase
is-TR-Pfnek3 and uniform loading of GST-Pfmap2 or its mutant in all
nd incubated for another 30 min at 30 C. The mixture was subjected to
s as was performed for (A) and (B). M = Peppermintstick protein
6090 Y.M. Lye et al. / FEBS Letters 580 (2006) 6083–6092approach was based on the use of a gel-based phosphoprotein
stain coupled to the ELISA microplate so that congruent re-
sults can be derived.
Since the N-terminal-deleted copy of Pfnek3 was catalyti-
cally active (Fig. 4C), it was used in subsequent experiments
involving kinase co-incubations. Gel-based phosphoprotein
staining indicated that GST-TR-Pfnek3 was able to phosphor-
ylate Pfmap2 (Fig. 5A). When DPfnek3 was used in place of
the wildtype enzyme, the observation of increased phosphory-
lation on Pfmap2 was abolished. This implied that GST-TR-
Pfnek3, and not bacterial kinases, was responsible for
phosphorylating GST-Pfmap2. This observation was corrobo-
rated by coating microplates with GST-Pfmap2 and using it as
a substrate for GST-TR-Pfnek3 (Fig. 5C). Uniformity in the
amount of adsorbed proteins was veriﬁed using anti-GST anti-
bodies versus blank-coated control wells (not shown). We ob-
served that GST-TR-Pfnek3, but not GST-DPfnek3, was able
to increase the phosphorylation state of Pfmap2 in ELISA as-
says (Fig. 5C). The reaction between Pfnek3 and Pfmap2 was
reciprocally performed and there was no signiﬁcant diﬀerence
between the phosphorylation statuses of Pfnek3 incubated
with either Pfmap2 or DPfmap2 (Fig. 5C). Therefore, the phos-
phorylation of Pfmap2 by Pfnek3 is directional.Fig. 6. Pfnek3 activates Pfmap2 but not hMAPK1. (A) GST-TR-
Pfnek3, when co-incubated with GST-Pfmap2 results in increased
phosphorylation of MBP. When GST-TR-Pfnek3 was replaced with
bacterially-expressed GST, GST-FL-Pfnek3 or GST-DPfnek3, this
phenomenon was not observed. To show that the enhancement in (A)
is speciﬁc to GST-Pfmap2, GST-Pfnek3 and its variants were co-
incubated with hMAPK1. Enhancements to kinase activity were not3.5. Pfnek3 stimulates Pfmap2 kinase activity
To assay for the eﬀect of Pfnek3 on Pfmap2 kinase activity,
fractions from the samples of kinase mixes destined for the gel-
based assay were transferred into MBP-coated ELISA plates
concurrently. MBP has been reported to be a suitable substrate
for Pfmap2 [4]. Using this assay format, GST-Pfmap2 alone
did not detectably phosphorylate MBP (Fig. 5D) vis-a`-vis
radioactive kinase assays [4]. Surprisingly, when GST-Pfmap2
was co-incubated with GST-Pfnek3, the levels of MBP phos-
phorylation were higher than the summation of the individ-
ual kinase activities (Fig. 5D). To eliminate the possibility
that the observed phosphorylation was due to contamination
of bacterial kinases or the GST moiety, GST-DPfnek3 or
GST-DPfmap2 was added to reaction mixtures containing
GST-Pfmap2 or GST-Pfnek3, respectively. In these controls,
there was no increase in MBP phosphorylation (Fig. 5D). To
support this observation, the experiment was repeated using
Western blot and probed for phospho-MBP with similar con-
clusions (Fig. 5E). To further demonstrate the notion that
Pfnek3 activates Pfmap2, GST-Pfmap2 was co-incubated
with His-TR-Pfnek3. The latter kinase was removed via nickel
aﬃnity chromatography and the separated GST-Pfmap2 dem-
onstrated enhanced MBP phosphorylation over controls con-
taining either GST-DPfmap2 or His-TR-DPfnek3 (Fig. 5F).
As demonstrated by experiments with catalytically-inactive
mutant enzymes, enhanced MBP phosphorylation was depen-
dent on the kinase activities of both Pfnek3 and Pfmap2.
However, when both kinases were co-incubated, ELISA and
gel-based assays indicated that the phosphorylation of Pfmap2
by Pfnek3 was directional. This suggests that Pfnek3 may be
upstream of Pfmap2 in a kinase cascade, at least in vitro.
observed. (B) Summary of data from co-incubation assays. (i) GST-
TR-Pfnek3 is an active kinase in the presence of Mn2+using MBP as
substrate. (ii) GST-Pfmap2 exhibits little or no activity using this assay
format. (iii) Adding GST-Pfmap2 to GST-TR-Pfnek3 enhanced MBP
phosphorylation. (iv) As control, adding another kinase (hMAPK1) to
GST-Pfnek3 counteracts MBP phosphorylation, hence suggesting that
the phenomenon of Pfnek3 stimulating Pfmap2 is not artefactual. (v)
GST-Pfmap1 was inert with GST-Pfnek3.3.6. Pfnek3 autophosphorylates in the presence of Pfmap2,
active or inactive
We noted with interest that the presence of Pfmap2 or
DPfmap2 was suﬃcient to cause an increase in phosphoryla-
tion on Pfnek3 versus samples containing Pfnek3 only(Fig. 5A), but does not possess detectable kinase activity alone
(Fig. 5D). Because both Pfmap2 and DPfmap2 did not detec-
tably phosphorylate Pfnek3 (Fig. 5C) and did not demonstrate
catalytic activity (Fig. 5D–E), it is possible that Pfnek3 autop-
hosphorylates in the presence of Pfmap2. The reason for this is
not entirely clear. Nevertheless, this observation indirectly
strengthens the postulation that the markedly increased kinase
activity of co-incubated Pfmap2 and Pfnek3 (Fig. 5D) was due
to the activity of Pfmap2 stimulated by Pfnek3, and not due to
the kinase activity of autophosphorylated Pfnek3 alone.
3.7. Pfnek3 stimulates Pfmap2 but not Pfmap1 or hMAPK1
To investigate whether the eﬀect is speciﬁc to Pfmap2 and
not other kinases, the same experiments were repeated with
two other kinases, where human MAPK1 (hMAPK1) or
GST-Pfmap1 was co-incubated with GST-Pfnek3 in a similar
fashion. Contrastingly, the incubation of GST-Pfnek3 with
hMAPK1 resulted in signiﬁcantly-decreased MBP phosphory-
lation levels (Fig. 6A). This was also observed in Western blot
experiments (Fig. 5E). To exclude the possibility that GST-FL-
Pfnek3 and GST-TR-Pfnek3 might also be substrates of GST-
hMAPK1, resulting in ATP exhaustion, the concentration of
ATP was increased from 100 to 500 lM in subsequent experi-
ments. However, the availability of excess ATP did not result
in increased MBP phosphorylation (not shown). Moreover, to
verify that the lack of MBP phosphorylation was not due to
insuﬃcient incubation time, the incubation period was ex-
Y.M. Lye et al. / FEBS Letters 580 (2006) 6083–6092 6091tended from 30 to 90 min with no detectable diﬀerence in activ-
ity (not shown). Next, to verify that the suppression of MBP
phosphorylation was not an artifact arising from the presence
of another free protein in excessive concentrations, GST-
hMAPK1 was co-incubated with bacterially-expressed GST
diluted to match the in vitro concentrations of GST-FL-
Pfnek3 and GST-TR-Pfnek3. GST did not inhibit GST-
hMAPK1 (Fig. 6A). Moreover, when GST was replaced with
DPfnek3, the inhibitory eﬀect remained intact (Fig. 6A).
To test whether GST-Pfnek3 has any role in regulating a
typical Plasmodium MAPK, GST-Pfmap1, the same kinase
co-incubation experiments were constructed. Despite being
solubly expressed (Fig. 3B), GST-Pfmap1 exhibited undetect-
able in vitro kinase activity using diﬀerent assay conditions
in this and other laboratories (C. Doerig, personal communi-
cation) contrary to a previous report of activity [3]. Addition-
ally, GST-Pfnek3 was unable to activate GST-Pfmap1 in thisFig. 7. Endogenous expression of Pfnek3. (A) Speciﬁcity of anti-Pfnek3 ant
Section 2. Scale bar represents 10 lm. (B) Schizonts (schiz) and gametocy
Hoechst 33342 conﬁrms the presence of parasite nuclei.study. A schematic summary of the results is recapitulated in
Fig. 6B.
3.8. Expression of endogenous Pfnek3
Although microarray data indicate predominant transcrip-
tional activity of Pfnek3 during the gametocyte stage [9], ac-
tual translational and subcellular localization information
remains unknown. This is especially important since the pres-
ence of a putative signal sequence in Pfnek3 suggested intracel-
lular protein transportation. With these questions in mind,
antibodies to Pfnek3 were raised (Fig. 7A) and immunoﬂuo-
rescence assays enabled the conﬁrmation of the transcriptome
data of Le Roch et al. [9] with regards to gametocyte-
stage Pfnek3 expression (Fig. 7B). Moreover, expression was
also detected in the late stages of asexual intraerythrocytic
parasites, despite no observable distinct patterns of localiza-
tion.ibody was veriﬁed with Western blots and ELISA, as described under
tes (gam) were positively-stained with anti-Pfnek3. Co-staining with
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Pfnek3 was demonstrated by microarray data to be highly
expressed in the gametocyte [9], and our immunoﬂuorescence
detection conﬁrms the same. Hence, Pfnek3 may be a possible
activator present in the gametocyte extract used to stimulate
Pfmap2 in an earlier study [4]. Contrastingly, this enhancement
was not observed when Pfmap2 was substituted by a hMAPK1
or Pfmap1, indicating the presence of a kinase-speciﬁc interac-
tion. Nevertheless, in vivo systems will have to be constructed
to further characterize their physiological roles in the gameto-
cyte.
Given that Pfnek3 is divergent from mammalian NEKs,
there is potential for Pfnek3 as a candidate drug target with
parasite-selective toxicity, provided the disruption of this gene
can be shown to hamper parasite development. To support this
endeavor, the microplate-based kinase inhibition assays are
poised strategically for high-throughput screening of com-
pound libraries, with lead compounds subsequently analyzed
for their eﬀects on parasite growth. Most importantly, the bio-
chemical eﬀects of Pfnek3 on various MAPKs may suggest an
unusual mode of eukaryotic MAPK interaction with an atyp-
ical member of the NIMA kinase family in the Plasmodium
parasite.
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